GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Net Issuance of Debt

Control Bionics (ASX:CBL) Net Issuance of Debt : A$-0.52 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Control Bionics Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Control Bionics's net issuance of debt for the six months ended in Dec. 2024 was A$-0.52 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.52 Mil.

Control Bionics Net Issuance of Debt Historical Data

The historical data trend for Control Bionics's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics Net Issuance of Debt Chart

Control Bionics Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Net Issuance of Debt
- 0.05 -0.05 0.52

Control Bionics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only -0.05 - - - -0.52

Control Bionics Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Control Bionics Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Control Bionics's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Control Bionics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Net Issuance of Debt
Comparable Companies
ASX:AT1 ASX:ADRDA ASX:HMD ASX:UCM ASX:IRX ASX:OSL ASX:UBI ASX:LDX ASX:CDX ASX:NTI ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
N/A
Address
11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Website
https://www.controlbionics.com
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.